Results 6,801-6,820 of 9,393 for speaker:Alex White
- Written Answers — Department of Health: Health Service Executive Properties (15 Nov 2012)
Alex White: An objective of the National Drugs Strategy 2009-16 is to develop a national treatment and rehabilitation service that provides drug free and harm reduction approaches for problem substance users and to encourage problem substance users to engage with, and avail of, such services. To this end the HSE provides a variety of drug treatment interventions to meet the needs of individual drug...
- Written Answers — Department of Health: Drugs Payment Scheme (15 Nov 2012)
Alex White: The information requested by the Deputy is not available to my Department or the HSE. The Drug Payment Scheme is not means-tested and anyone ordinarily resident in Ireland can apply to join the Scheme, regardless of financial circumstances.
- Written Answers — Department of Health: Medical Card Application Numbers (15 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Medical Card Applications (14 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Medical Card Application Numbers (14 Nov 2012)
Alex White: I am advised by the HSE that in total, 11,800 discretionary medical cards and GP visit cards were issued or renewed from January to September 2012. Medical cards are not awarded to any particular group of patients on the basis of a specific medical condition. Under the provisions of the Health Act 1970, eligibility for health services in Ireland is based primarily on residency and means....
- Written Answers — Department of Health: Medical Card Applications (14 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Medical Card Review (14 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Medical Card Applications (14 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Drug Treatment Programmes (14 Nov 2012)
Alex White: Coolmine Therapeutic Community receives funding from my Department and the HSE to provide a range of services, including a specific residential programme targeting women, many of whom are mothers. Reflecting the Government's ongoing commitment to the National Drugs Strategy, I have approved an additional €100,000 in funding to enable the facility to provide a creche service. This...
- Written Answers — Department of Health: Hospital Services (14 Nov 2012)
Alex White: As this is a service matter it has been referred to the HSE for direct reply.
- Written Answers — Department of Health: Medical Cards (14 Nov 2012)
Alex White: The current financial environment the Health Service Executive (HSE) is facing a challenge to deliver services in a way that will minimise any adverse impact on patients and continue to protect, as far as possible, the most vulnerable citizens. Unfortunately, it has become necessary for the HSE to suspend certain products from its list of reimbursable items. These include glucosamine,...
- Written Answers — Department of Health: Medical Card Applications (14 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Health Service Staff (14 Nov 2012)
Alex White: The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible.
- Written Answers — Department of Health: Supplementary Welfare Allowance Diet Supplement (13 Nov 2012)
Alex White: In the current financial environment the Health Service Executive (HSE) is facing a challenge to deliver services in a way that will minimise any adverse impact on patients and continue to protect, as far as possible, the most vulnerable citizens. Unfortunately, it has become necessary for the HSE to suspend certain products from its list of reimbursable items. This includes gluten-free...
- Written Answers — Department of Health: Drug Treatment Programmes (13 Nov 2012)
Alex White: Coolmine Therapeutic Community receives funding from my Department and the HSE to provide a range of services, including a specific residential programme targeting women, many of whom are mothers. Reflecting the Government's ongoing commitment to the National Drugs Strategy, I have approved an additional €100,000 in funding to enable the facility to provide a creche service. This will...
- Written Answers — Department of Health: Drug Treatment Programmes (13 Nov 2012)
Alex White: I am not aware of the basis for the statement referred to by the Deputy. The development of integrated treatment and rehabilitation services for problem substance users is a key focus of the National Drugs Strategy 2009-2016. Indeed, over half of the €250m approximately that is allocated by Departments and agencies to drugs programmes is expended under the Treatment and...
- Written Answers — Department of Health: Health Service Expenditure (13 Nov 2012)
Alex White: The cost to the Health Service Executive of antidepressants and anxiolytics for 2009, 2010 and 2011 is set out in the table. 2009 2010 2011 Antidepressants €81,374,005 €67,303,876 €67,220,203 Anxiolytics €10,739,808 €9,747,964 €9,606,691
- Written Answers — Department of Health: Medical Card Applications (13 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Medical Card Delays (13 Nov 2012)
Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.
- Written Answers — Department of Health: Medicinal Products (13 Nov 2012)
Alex White: Regulation 7(5) of the Medicinal Products (Prescription and Control of Supply) Regulations 2003 as amended provides that prescriptions for medicinal products are valid for a period of six months from the date specified on the prescription. Prescriptions for Controlled Drugs, which are listed in Schedule 2 and 3 of the Misuse of Drugs Regulations 1988 as amended, are valid for fourteen days...